Skip to content

Jolien Veraart

Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; PsyQ Haaglanden, Parnassia Psychiatric Institute, The Hague, Netherlands.

3 papers in the library · 93 citations · publishing 2022-2025

Papers

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study.

Frontiers in psychiatry January 1, 2022 Joost J Breeksema, Alistair Niemeijer, Bouwe Kuin et al. 41 citations

Patients with treatment-resistant depression undergoing oral esketamine treatment often find the experience overwhelming and struggle with whether to let go or maintain control. Their ability to let go is influenced by preparation, emotional support, and the treatment setting. Better preparation, an optimized environment, and psychological support during sessions may improve patients' experiences and outcomes. The study provides recommendations for improving quality of care, including training for nurses and support staff.

Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.

The lancet. Psychiatry January 1, 2025 Carolina Seybert, Nina Schimmers, Lucio Silva et al. 26 citations

Reporting on the psychological intervention component of psychedelic-assisted psychotherapy is mostly incomplete and inconsistent across studies, limiting replicability and clinical translation. A systematic review of 45 original studies on psilocybin, MDMA, LSD, or ayahuasca for mental disorders found that descriptions of psychotherapy varied widely and completeness of information was generally low, based on an adapted Template for Intervention Description and Replication checklist. Studies involving MDMA showed more homogeneous psychotherapy and more procedural details. Improved reporting on psychological interventions would support replicability, generalisability, and accurate interpretation of research, as well as enhance feasibility and safety of future clinical research and real-world implementation.

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study.

Psychopharmacology July 1, 2023 Joost J Breeksema, Alistair Niemeijer, Bouwe Kuin et al. 26 citations

The effects of oral esketamine for treatment-resistant depression are highly variable, and psychological distress is common. Patients report perceptual changes, detachment from body and emotions, stillness, mystical-type experiences, and fear. After sessions, many feel hungover and fatigued, while depressive mood is neutralized. Some effects, such as increased openness and detachment, may hold psychotherapeutic potential, but the frequent distress calls for additional patient support throughout treatment.